183 related articles for article (PubMed ID: 21892657)
1. CETP polymorphisms associate with brain structure, atrophy rate, and Alzheimer's disease risk in an APOE-dependent manner.
Murphy EA; Roddey JC; McEvoy LK; Holland D; Hagler DJ; Dale AM; Brewer JB;
Brain Imaging Behav; 2012 Mar; 6(1):16-26. PubMed ID: 21892657
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk for Alzheimer's disease as a modifier for APOE epsilon4 in Chinese.
Chen DW; Yang JF; Tang Z; Dong XM; Feng XL; Yu S; Chan P
Brain Res; 2008 Jan; 1187():52-7. PubMed ID: 18036514
[TBL] [Abstract][Full Text] [Related]
4. The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease.
Arias-Vásquez A; Isaacs A; Aulchenko YS; Hofman A; Oostra BA; Breteler M; van Duijn CM
Neurogenetics; 2007 Aug; 8(3):189-93. PubMed ID: 17503098
[TBL] [Abstract][Full Text] [Related]
5. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
[TBL] [Abstract][Full Text] [Related]
6. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
[TBL] [Abstract][Full Text] [Related]
7. Inheritance of the ApoE epsilon4 allele increases the rate of brain atrophy in dementia patients.
Wahlund LO; Julin P; Lannfelt L; Lindqvist J; Svensson L
Dement Geriatr Cogn Disord; 1999; 10(4):262-8. PubMed ID: 10364643
[TBL] [Abstract][Full Text] [Related]
8. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
Susanto TA; Pua EP; Zhou J;
J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
[TBL] [Abstract][Full Text] [Related]
9. Effect of the brain-derived neurotrophic factor and the apolipoprotein E polymorphisms on disease progression in preclinical Alzheimer's disease.
Hashimoto R; Hirata Y; Asada T; Yamashita F; Nemoto K; Mori T; Moriguchi Y; Kunugi H; Arima K; Ohnishi T
Genes Brain Behav; 2009 Feb; 8(1):43-52. PubMed ID: 18786162
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Wolk DA; Dickerson BC;
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936.
Lyall DM; Harris SE; Bastin ME; Muñoz Maniega S; Murray C; Lutz MW; Saunders AM; Roses AD; Valdés Hernández Mdel C; Royle NA; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
Neurobiol Aging; 2014 Jun; 35(6):1513.e25-33. PubMed ID: 24508314
[TBL] [Abstract][Full Text] [Related]
13. Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's disease.
Morgen K; Ramirez A; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S269-76. PubMed ID: 24613704
[TBL] [Abstract][Full Text] [Related]
14. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
15. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
16. Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions.
Qureischie H; Heun R; Popp J; Jessen F; Maier W; Schmitz S; Hentschel F; Kelemen P; Kölsch H
J Neural Transm (Vienna); 2009 Apr; 116(4):467-72. PubMed ID: 19184337
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: A Northern Greece Study.
Tsolaki AC; Gatzima O; Daniilidou M; Lazarou E; Bamidis PD; Verykouki E; Iakovidou-Kritsi Z; Tsolaki M
Neurodegener Dis; 2018; 18(4):216-224. PubMed ID: 30205398
[TBL] [Abstract][Full Text] [Related]
18. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
19. Association of APOE and CETP TaqIB Polymorphisms with Type 2 Diabetes Mellitus.
Srirojnopkun C; Kietrungwilaikul K; Boonsong K; Thongpoonkaew J; Jeenduang N
Arch Med Res; 2018 Oct; 49(7):479-485. PubMed ID: 30853126
[TBL] [Abstract][Full Text] [Related]
20. Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.
Drzezga A; Grimmer T; Henriksen G; Mühlau M; Perneczky R; Miederer I; Praus C; Sorg C; Wohlschläger A; Riemenschneider M; Wester HJ; Foerstl H; Schwaiger M; Kurz A
Neurology; 2009 Apr; 72(17):1487-94. PubMed ID: 19339712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
